Scorpius Holdings, Inc. (SCPX)

USD 0.04

(-9.53%)

Inventory Summary of Scorpius Holdings, Inc.

  • Scorpius Holdings, Inc.'s latest annual inventory in 2023 was 909.15 Thousand USD , down -57.58% from previous year.
  • Scorpius Holdings, Inc.'s latest quarterly inventory in 2024 Q2 was 70.82 Thousand USD , down -95.1% from previous quarter.
  • Scorpius Holdings, Inc. reported annual inventory of 2.14 Million USD in 2022, down -11.67% from previous year.
  • Scorpius Holdings, Inc. reported annual inventory of 2.42 Million USD in 2021, up 49.85% from previous year.
  • Scorpius Holdings, Inc. reported quarterly inventory of 70.82 Thousand USD for 2024 Q2, down -95.1% from previous quarter.
  • Scorpius Holdings, Inc. reported quarterly inventory of 2.39 Million USD for 2023 Q1, down 0.0% from previous quarter.

Annual Inventory Chart of Scorpius Holdings, Inc. (2023 - 2015)

Historical Annual Inventory of Scorpius Holdings, Inc. (2023 - 2015)

Year Inventory Inventory Growth
2023 909.15 Thousand USD -57.58%
2022 2.14 Million USD -11.67%
2021 2.42 Million USD 49.85%
2020 1.61 Million USD 0.0%
2019 - USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%
2015 - USD 0.0%

Peer Inventory Comparison of Scorpius Holdings, Inc.

Name Inventory Inventory Difference
AIM ImmunoTech Inc. -1.18 Million USD 176.787%
Armata Pharmaceuticals, Inc. - USD -Infinity%
Actinium Pharmaceuticals, Inc. - USD -Infinity%
Azitra, Inc. -215.21 Thousand USD 522.434%
Can-Fite BioPharma Ltd. - USD -Infinity%
Chromocell Therapeutics Corporation - USD -Infinity%
Calidi Biotherapeutics, Inc. - USD -Infinity%
CEL-SCI Corporation 2.24 Million USD 59.558%
iBio, Inc. - USD -Infinity%
Lineage Cell Therapeutics, Inc. - USD -Infinity%
MAIA Biotechnology, Inc. - USD -Infinity%
Matinas BioPharma Holdings, Inc. - USD -Infinity%
NovaBay Pharmaceuticals, Inc. 2.87 Million USD 68.399%
NanoViricides, Inc. - USD -Infinity%
Oragenics, Inc. - USD -Infinity%
BiomX Inc. - USD -Infinity%
BiomX Inc. - USD -Infinity%
Protalix BioTherapeutics, Inc. 19.04 Million USD 95.226%
Palatin Technologies, Inc. - USD -Infinity%
Theriva Biologics, Inc. - USD -Infinity%